Generalmente, el tratamiento con la liraglutida produce una disminucin de 0,8 a 1,5% en los niveles de HbA1C, asociado a la prdida de peso y la disminucin en la frecuencia de hipoglicemias56
Handling : Grasp only the syringe flange and plunger button to avoid altering measurements with body heat
It's particularly warranted if mood symptoms are accompanied by neurological signs (numbness, tingling, balance issues) or anemia symptoms (fatigue, pallor, shortness of breath)
While the exact prevalence can vary, clinical trials and patient reports indicate that gastrointestinal side effects, including heartburn, are relatively common with semaglutide use
Furthermore, there may be concerns regarding the long-term safety profile and uncommon adverse effects associated with GLP-1 receptor agonists, which may limit their use in specific patient populations